Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) targeting central nervous system disorders. Its structure supports the creation of bioactive molecules with potential antipsychotic or dopaminergic activity. Commonly utilized in research settings for medicinal chemistry projects involving piperazine-based derivatives. Also serves as a building block in the preparation of fluorinated organic compounds to enhance metabolic stability and binding affinity in drug candidates.